Sidney Himmel has been involved in financing Cannabis and cannabinoid related companies since early 2016. He is currently Chairman of Khiron Life Sciences Corp., a Canadian vertically integrated medical cannabis company with operations in Latin America. He was previously Chairman of Namaste Technologies Inc. He is the founder of GPCR Pharmaceuticals Inc., a private life sciences company developing cannabinoid-based pharmaceuticals as ethical drugs. GPCR is focused primarily on the dermatological space. He holds a degree in Chemistry, and also is trained in finance, and worked for 30 years in capital markets, having raised significant amounts of funds for private and public companies in numerous industries including biotechnology and resources. His primary financing interests in involve public equity, and his primary interest in operations involve life sciences and drug development.
ICAN HQ: Beit Shemesh, Israel
5 HaUman, Industrial Zone, Beit Shemesh
CannaTech isn't just and incredible, global event experience...
it is the future of cannabis